Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kelly Gash
Active8: A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination With TLR8 Agonist VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Cetuximab Plus Platinum-Based Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Randomized, Double-Blind Safety Study Comparing Cetuximab Produced From Two Manufacturing Processes Using the EXTREME Study Regimen
BMC Cancer
Cancer Research
Oncology
Genetics
A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma
Oral Oncology
Cancer Research
Oral Surgery
Oncology
Genetic Landscape of Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma
Journal of Clinical Investigation
Medicine
Pcn105 - Economic Burden of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Nivolumab in the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (RM-SCCHN): A Report of 16 Cases at a Single Institution
International Journal of Practical Otolaryngology
Socioeconomic Factors and Survival in Patients With Non-Metastatic Head and Neck Squamous Cell Carcinoma
Cancer Science
Cancer Research
Medicine
Oncology
A Phase I Dose Escalation Trial of MAGE-A3 and HPV-16 Specific Peptide Immunomodulatory Vaccines in Patients With Recurrent/Metastatic (RM) Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
SUPREME-HN: A Retrospective Biomarker Study Assessing the Prognostic Value of PD-L1 Expression in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology